---
title: "Refining a metabolite-based distress score for diverse US populations: development of an MDS-ME"
id: "medrxiv-14-assessing-and-refining-a-metabolite-based-distress-score-for-use-in-different"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-assessing-and-refining-a-metabolite-based-distress-score-for-use-in-different"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.10.26362734v1?rss=1"
published_at: "2026-09-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Refining a metabolite-based distress score for diverse US populations: development of an MDS-ME
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-assessing-and-refining-a-metabolite-based-distress-score-for-use-in-different
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.10.26362734v1?rss=1)
- **Published At:** 2026-09-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study evaluated a previously developed **metabolite-based distress score (MDS)**, initially derived in predominantly White women, across diverse populations in three US cohorts: **MESA**, **WHI**, and **NHS**. - Researchers tested whether the original 20-metabolite MDS associated with **depression** similarly in White and Black participants and in men and women. - The investigation was performed in four stages using baseline plasma metabolomics and depression status in MESA, with derivation and replication steps that included WHI and NHS. - Stage 1 applied the existing MDS to 2,477 White and 1,625 Black MESA participants to assess associations with prevalent depression; results showed a stronger association in White participants (OR 1.93, 95% CI 1.71–2.19) than in Black participants (OR 1.13, 95% CI 0.97–1.33). - Stage 2 performed an agnostic metabolite analysis among a 70% random subset of Black MESA participants to identify additional metabolites relevant to distress in this population. - Stage 3 used those findings to derive a **multi-ethnic MDS (MDS-ME)** comprising 33 metabolites among Black participants. - The derived **MDS-ME** showed a stronger association with depression in Black MESA participants (OR 1.45, 95% CI 1.04–2.03) than the original MDS, while retaining associations in White participants (OR 1.81, 95% CI 1.60–2.04). - Stage 4 tested the MDS-ME in independent samples from MESA, WHI, and NHS; associations were also observed in Black women in WHI and NHS. - The authors conclude that incorporating metabolites identified in Black participants improves the utility and generalizability of the **MDS** across more diverse populations. - Ethical approvals and participant consent were obtained; the University of Massachusetts Amherst IRB provided ethical approval. Funding sources included NIH and USDA/ARS. Competing interests were limited; one author consults for Westat.
## Clinical Analysis & Structured Key Points
Assessing and refining a metabolite-based distress score for use in different populations within three US cohorts | medRxiv Skip to main content Assessing and refining a metabolite-based distress score for use in different populations within three US cohorts Tianyi Huang , Yiwen Zhu , Raji Balasubramanian , Andrea Roberts , View ORCID Profile Clary B Clish , Julian Avila Pacheco , Jerome Rotter , Xiuqing Guo , Jie Yao , Yii-Der Ida Chen , Steve Rich , Kent Taylor , Alexis Wood , W. Craig Johnson , View ORCID Profile Katherine H. Shutta , Kathryn Rexrode , Aladdin H Shadyab , Su Yon Jung , JoAnn E Manson , Susan E. Hankinson , Laura D. Kubzansky doi: https://doi.org/10.64898/2026.09.10.26362734 Tianyi Huang 1 Intramural Research Program, National Institute on Aging; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: tianyi.huang{at}nih.gov Yiwen Zhu 2 Harvard University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Raji Balasubramanian 3 University of Massachusetts Amherst; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Andrea Roberts 2 Harvard University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Clary B Clish 4 Broad Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Clary B Clish Julian Avila Pacheco 5 The Broad Institute of MIT and Harvard; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jerome Rotter 6 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xiuqing Guo 6 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jie Yao 7 The Lundquist Institute for Biomedical Innovation; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yii-Der Ida Chen 8 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Steve Rich 9 Virginia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kent Taylor 6 The Lundquist Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alexis Wood 10 Baylor College of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site W. Craig Johnson 11 University of Washington; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Katherine H. Shutta 12 Harvard T.H. Chan School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Katherine H. Shutta Kathryn Rexrode 13 Brigham and Women's Hospital, Harvard Medical School; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aladdin H Shadyab 14 University of California, San Diego; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Su Yon Jung 15 University of California Los Angeles; Find this author on Google Scholar Find this author on PubMed Search for this author on this site JoAnn E Manson 16 Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Susan E. Hankinson 3 University of Massachusetts Amherst; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Laura D. Kubzansky 17 Harvard TH Chan School of Public Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Introduction: Psychological distress is associated with metabolic alterations that contribute to adverse cardiometabolic outcomes across diverse populations. We previously developed a metabolite-based distress score (MDS) in predominantly White women. Because men and Black individuals suffer high rates of cardiometabolic disease, we evaluated whether the MDS is similarly associated with depression in these populations, and derived a multi-ethnic MDS (MDS-ME) among Black individuals with replications in independent samples. Methods: Data were from three U.S. cohorts, the Multi-Ethnic Study of Atherosclerosis (MESA), Women's Health Initiative (WHI), and Nurses' Health Study (NHS), evaluated in 4 stages. Stages 1-3 included 2,477 White and 1,625 Black MESA participants with depression status data and plasma metabolomics assessed at baseline. Stage 1: We calculated the MDS and examined its association with depression status. Stage 2: We conducted an agnostic analysis among a 70% random subset of Black participants to identify additional relevant metabolites. Stage 3: We derived an MDS-ME in Black participants. Stage 4: We evaluated the MDS-ME using independent samples from all three cohorts. Results: The previously validated 20-metabolite MDS showed stronger associations with prevalent depression in White (OR: 1.93, 95% CI: 1.71, 2.19) versus Black (OR: 1.13, 95% CI: 0.97, 1.33) MESA participants. Associations were generally similar in men and women. The MDS-ME comprised 33 metabolites, and relative to the MDS was more strongly associated with depression in Black participants (OR: 1.45; 95% CI: 1.04, 2.03), with associations also evident in White participants (OR: 1.81; 95% CI: 1.60, 2.04). The MDS-ME was similarly associated with depression in Black women in WHI and NHS. Conclusion: Results suggest that incorporating metabolites identified in Black participants enhances the utility and generalizability of the MDS across more diverse populations. Competing Interest Statement Dr. Rich is a consultant to Westat, the Administrative Coordinating Center for the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. All other authors report no biomedical financial interests or potential conflicts of interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: IRB of University of Massachusetts Amherst gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88 , R01AG051600 National Institute on Aging, https://ror.org/049v75w11 , ZIAAG000530 USDA/ARS , 58-3092-5-001 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 13, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Assessing and refining a metabolite-based distress score for use in different populations within three US cohorts Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Assessing and refining a metabolite-based distress score for use in different populations within three US cohorts Tianyi Huang , Yiwen Zhu , Raji Balasubramanian , Andrea Roberts , Clary B Clish , Julian Avila Pacheco , Jerome Rotter , Xiuqing Guo , Jie Yao , Yii-Der Ida Chen , Steve Rich , Kent Taylor , Alexis Wood , W. Craig Johnson , Katherine H. Shutta , Kathryn Rexrode , Aladdin H Shadyab , Su Yon Jung , JoAnn E Manson , Susan E. Hankinson , Laura D. Kubzansky medRxiv 2026.09.10.26362734; doi: https://doi.org/10.64898/2026.09.10.26362734 Share This Article: Copy Citation Tools Assessing and refining a metabolite-based distress score for use in different populations within three US cohorts Tianyi Huang , Yiwen Zhu , Raji Balasubramanian , Andrea Roberts , Clary B Clish , Julian Avila Pacheco , Jerome Rotter , Xiuqing Guo , Jie Yao , Yii-Der Ida Chen , Steve Rich , Kent Taylor , Alexis Wood , W. Craig Johnson , Katherine H. Shutta , Kathryn Rexrode , Aladdin H Shadyab , Su Yon Jung , JoAnn E Manson , Susan E. Hankinson , Laura D. Kubzansky medRxiv 2026.09.10.26362734; doi: https://doi.org/10.64898/2026.09.10.26362734 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (617) Allergy and Immunology (900) Anesthesia (330) Cardiovascular Medicine (4806) Dentistry and Oral Medicine (478) Dermatology (414) Emergency Medicine (648) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1626) Epidemiology (15929) Forensic Medicine (32) Gastroenterology (1202) Genetic and Genomic Medicine (7038) Geriatric Medicine (733) Health Economics (1064) Health Informatics (5035) Health Policy (1433) Health Systems and Quality Improvement (1760) Hematology (584) HIV/AIDS (1344) Infectious Diseases (except HIV/AIDS) (16285) Intensive Care and Critical Care Medicine (1171) Medical Education (667) Medical Ethics (153) Nephrology (722) Neurology (7262) Nursing (366) Nutrition (1080) Obstetrics and Gynecology (1240) Occupational and Environmental Health (1004) Oncology (3603) Ophthalmology (1049) Orthopedics (397) Otolaryngology (453) Pain Medicine (470) Palliative Medicine (139) Pathology (706) Pediatrics (1797) Pharmacology and Therapeutics (737) Primary Care Research (765) Psychiatry and Clinical Psychology (5887) Public and Global Health (9744) Radiology and Imaging (2415) Rehabilitation Medicine and Physical Therapy (1449) Respiratory Medicine (1247) Rheumatology (640) Sexual and Reproductive Health (771) Sports Medicine (578) Surgery (776) Toxicology (107) Transplantation (305) Urology (291)
## Related Clinical Research

- [Men with Multiple Long-Term Conditions and Disability in the Game of Stones Weight Management Trial](https://medichelpline.com/clinical-feed/bmj-open-2-mens-experiences-of-multiple-long-term-conditions-and-or-disability-in-the-uk.md)
- [Rising Demand for Plastic Surgery Among Young Men Fueled by Influencers and Looksmaxxing](https://medichelpline.com/clinical-feed/stat-news-1-opinion-more-young-men-are-coming-to-me-for-plastic-surgery-the-way-i-think.md)
- [Medicare expands ACCESS pilot to cover more chronic conditions and lists 39 providers](https://medichelpline.com/clinical-feed/stat-news-1-stat-medicare-to-expand-its-pilot-that-pays-for-technology-to-manage-chronic.md)
- [Victimisation, depression and suicidal ideation among North Indian youth: a structural equation an](https://medichelpline.com/clinical-feed/medrxiv-8-victimisation-depression-and-suicidal-ideation-understanding-interlinkages.md)
- [Multimorbidity and mental health in older Chinese adults: how family and social support modify risk](https://medichelpline.com/clinical-feed/plos-one-23-chronic-disease-multimorbidity-and-mental-health-among-older-adults-in-china.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.